Effect of Blueberries on Cognition and Body Composition in Elderly With Mild Cognitive Decline
- Conditions
- Mild Cognitive Decline
- Interventions
- Dietary Supplement: Dextrose PlaceboDietary Supplement: Freeze-dried blueberries
- Registration Number
- NCT01515098
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Brief Summary
Purpose: The purpose of this study is to examine the effect of blueberry consumption on cognitive decline and body composition in humans.
Hypothesis 1: Adults with mild cognitive decline who consume blueberries will experience an improvement in cognitive abilities as measured by a standardized battery of tests, relative to those who consume a placebo.
Hypothesis 2: Adults with mild cognitive decline who consume blueberries will evidence an increase in processing speed and an improvement in memory abilities as measured in an electrophysiological paradigm and compared to those who consume a placebo.
Hypothesis 3: Daily intake of 35 g freeze-dried blueberries will improve body composition (fat mass vs. lean mass).
Hypothesis 4: Daily intake of 35 g freeze-dried blueberries will decrease oxidative stress and inflammatory markers.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 123
- Men and women age 65 and older
- BMI between 18.5 and 34.5
- Close individual to report memory decline
- History of central nervous system or psychiatric disorders
- Dementia or Alzheimer's diagnosis
- Diabetes
- Smoking >20 cigarettes/day
- Gastrointestinal/digestive disorders
- Uncontrolled chronic disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Group Dextrose Placebo 37 grams of dextrose powder daily for 6 months Blueberry Group Freeze-dried blueberries 37 grams of dehydrated blueberries daily for 6 months
- Primary Outcome Measures
Name Time Method Change in cognitive test performance Baseline, 180 days Measured by CANTAB
Change in brain activity (N200, P300) related to cognitive abilities as measured by event-related potentials (ERP) Baseline, 180 days Recognition memory, speed of processing, and memory consolidation as measured by the electrophysiological technique known as event-related potentials (ERP)
- Secondary Outcome Measures
Name Time Method Change in body mass distribution Baseline, 180 days DXA scans to measure body composition at baseline and outcome will be compared for differences
Change in oxidative stress and inflammatory markers as measured in blood and urine Baseline, 180 days Oxidative stress and inflammatory markers will be measured in blood and compared between baseline and outcome.
Trial Locations
- Locations (1)
Nutrition Research Institute
🇺🇸Kannapolis, North Carolina, United States